Učitavanje...
A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is the reason for this ongoing pandemic infection diseases termed coronavirus disease 2019 (COVID-19) that has emerged since early December 2019 in Wuhan City, Hubei Province, China. In this century, it is the worst threat to international...
Spremljeno u:
| Izdano u: | Naunyn Schmiedebergs Arch Pharmacol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Berlin Heidelberg
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7235439/ https://ncbi.nlm.nih.gov/pubmed/32430617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00210-020-01901-6 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|